Johnson & Johnson Drug Approved for Rare Blood Disorder

The U.S. Food and Drug Administration (FDA) has approved the expanded use of Johnson & Johnson’s drug Imaavy to treat a rare blood disorder. According...

Read full coverage on TraceNews